Activation of the AMP-Activated Protein Kinase by Eicosapentaenoic Acid (EPA, 20:5 n-3) Improves Endothelial Function In Vivo
Year: 2012
Type: article
Abstract: The aim of the present study was to test the hypothesis that the cardiovascular-protective effects of eicosapentaenoic acid (EPA) may be due, in part, to its ability to stimulate the AMP-activated protein kinase (AMPK)-induced endothelial nitric oxide synthase (eNOS) activation. The role of AMPK in EPA-induced eNOS phosphorylation was investigated in bovine aortic endothelial cells (BAEC), in mice deficient of either AMPKα1 or AMPKα2, in eNOS knockout (KO) mice, or in Apo-E/AMPKα1 dual KO mice. EPA-treatment of BAEC increased both AMPK-Thr172 phosphorylation and AMPK activity, which was accompanied by increased eNOS phosphorylation, NO release, and upregulation of mitochondrial uncoupling protein-2 (UCP-2). Pharmacologic or genetic inhibition of AMPK abolished EPA-enhanced NO release and eNOS phosphorylation in HUVEC. This effect of EPA was absent in the aortas isolated from either eNOS KO mice or AMPKα1 KO mice fed a high-fat, high-cholesterol (HFHC) diet. EPA via upregulation of UCP-2 activates AMPKα1 resulting in increased eNOS phosphorylation and consequent improvement of endothelial function in vivo.
Source: PLoS ONE
Authors: Yong Wu, Cheng Zhang, Yunzhou Dong, Shuangxi Wang, Ping Song, Benoit Viollet, Ming-Hui Zou
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
Awards: Clinical Testing of the First Suspension BHK-M Cell Platform Derived Biotherapeutic, G2019914985, Prevention of High Fat Diet-Induced Vascular Injury, Autophagy and diabetic vascular diseases, AMP-activated protein kinase in diabetes, G7546854723, Development of a novel production platform for complex recombinant biotherapeutic, Controlling atherosclerotic plaque stability, Inflammasome and unstable atherosclerotic plaques, Angiotensin-II, GTPCH1 and 26S Protesomes, Hematology Clinical Research Training Program
OpenAlex ID: W2040165379
